World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
UK
2026

D-Index & Metrics

Best Scientists

D-Index
226
Citations
296149
World Ranking
109
National Ranking
13

Medicine

D-Index
228
Citations
283029
World Ranking
66
National Ranking
8

John J.V. McMurray publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John J.V. McMurray sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,244 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John J.V. McMurray D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John J.V. McMurray sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 228 D-Index — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • 2022 - Research.com Medicine in United Kingdom Leader Award
  • 2008 - Fellow of the Royal Society of Edinburgh
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

John J.V. McMurray is affiliated with the University of Glasgow in the United Kingdom. Their research primarily focuses on Medicine, with a strong emphasis on Cardiology and Cardiovascular Medicine. Other notable subfields of study include Endocrinology, Diabetes and Metabolism, Surgery, Pulmonary and Respiratory Medicine, and Nephrology.

The scientist's main topics of work cover several critical areas, including:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Diabetes Treatment and Management
  • Pancreatic Function and Diabetes
  • Cardiac Pacing and Defibrillation Studies
  • Hormonal Regulation and Hypertension
  • Potassium and Related Disorders

McMurray has contributed numerous papers to leading journals. Recent notable publications include:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2021, European Heart Journal
  • Dapagliflozin in Patients with Chronic Kidney Disease, 2020, New England Journal of Medicine
  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction, 2022, New England Journal of Medicine
  • Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19, 2020, New England Journal of Medicine
  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2022, European Journal of Heart Failure

Their frequent co-authors include:

  • Scott D. Solomon
  • Pardeep S. Jhund
  • Brian Claggett
  • Muthiah Vaduganathan
  • Akshay S. Desai

John J.V. McMurray has published extensively in several well-regarded scientific journals. The most frequent publication venues are:

  • European Journal of Heart Failure
  • European Heart Journal
  • JACC Heart Failure
  • Journal of the American College of Cardiology
  • Circulation

The scientist has received recognition including being named a Fellow of the Royal Society of Edinburgh in 2008 and elected as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler

  • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

    Theresa A McDonagh;Marco Metra;Marianna Adamo;Roy S Gardner

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • Angiotensin-neprilysin inhibition versus enalapril in heart failure.

    John J. V. McMurray;Milton Packer;Akshay S. Desai;Jianjian Gong

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler

  • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

    Christopher B Granger;John J V McMurray;Salim Yusuf;Peter Held

  • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

    Salim Yusuf;Marc A Pfeffer;Karl Swedberg;Christopher B Granger

  • Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

    Faiez Zannad;John J. V. McMurray;Henry Krum;Dirk J. van Veldhuisen

  • Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology

    Alec Vahanian;Helmut Baumgartner;Jeroen Bax;Eric Butchart

  • Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

    Scott D. Solomon;John J.V. McMurray;Marc A. Pfeffer;Janet Wittes

  • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

    Marc A Pfeffer;Karl Swedberg;Christopher B Granger;Peter Held

  • Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

    Nagesh S Anavekar;John J V McMurray;Eric J Velazquez;Scott D Solomon

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper

Frequent Co-Authors

Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Karl Swedberg
Karl Swedberg University of Gothenburg
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Pardeep S. Jhund
Pardeep S. Jhund University of Glasgow
Lars Køber
Lars Køber Copenhagen University Hospital
Michael R. Zile
Michael R. Zile Medical University of South Carolina
Mark C. Petrie
Mark C. Petrie University of Glasgow
Brian Claggett
Brian Claggett Brigham and Women's Hospital
Akshay S. Desai
Akshay S. Desai Brigham and Women's Hospital
Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of online healthcare degrees and career paths. If you’re looking for flexible options with strong job prospects, you might consider online medical billing and coding schools that accept fafsa. These programs allow you to begin a vital healthcare career in as little as one year, with financial aid available.

For those interested in direct patient care but concerned about entrance exams, several nursing school that doesn't require teas provide a quicker, less stressful path to a nursing credential.

If rapid advancement is your goal, consider accelerated healthcare programs. These shorten the time needed to earn a bachelor’s or master’s degree in healthcare administration, preparing you faster for leadership roles.

Registered nurses seeking further advancement can explore asn to np bridge programs, which connect an associate’s degree in nursing to a nurse practitioner credential. Whatever your interests, online programs offer flexible entry points for aspiring healthcare professionals.

Best Scientists Citing John J.V. McMurray

Trending Scientists

Recently Published Articles